A multi-faceted retrospective review of immunization status was undertaken, with hospital records audited, a telephone interview survey conducted with consenting parents and the vaccination history was checked against the primary care physician and Australian Childhood Immunization Register (ACIR) records. The routine primary childhood vaccinations and administration of the recommended additional influenza and pneumococcal vaccines was clarified. Results This 2007 audit reviewed the immunization status of 101individuals on the Victorian Pediatric IBD database. Median age at diagnosis was 12.1 years, 50% were on active immunosuppressive therapy. 90% (38/42) [95% confidence intervals (CI) 77%; 97%] with complete immunization information were up-to-date with routine primary immunizations. Only 5% (5/101) [95% CI 2%; 11%] received a recommended pneumococcal vaccine booster and 10% (10/101) [95% CI 5%; 17%] had evidence of having ever received a seasonal influenza vaccine. Those living in rural Victoria (p = 0.005) and younger at the age of diagnosis (p = 0.002) were more likely to have ever received an influenza vaccine Serological testing, reviewing historical protection from VPD, identified 18% (17/94) with evidence of at least one serology sample. Conclusion This study highlights poor compliance in IBD patients for additional recommended vaccines. A multi-faceted approach is required to maximize protection from VPD in this vulnerable special risk population. Keywords: pediatric; infections; inflammatory bowel disease; immunosuppressed; immunization Background The prevention of vaccine preventable diseases (VPD) in all individuals with inflammatory bowel disease (IBD) is increasingly recognised as important [ 1 – 3 ]. IBD rates have increased globally over the past 30 years, including in the Australian state of Victoria, where the incidence of Crohn’s disease rose from 0.128 to 2.0 per 100 000 per year over a 31-year period (1971-2001) [ 4 ]. Immunosuppressive therapies such as corticosteroids and azathioprine have long been used in IBD management.
more tips here http://www.biomedcentral.com/1471-230X/11/87
Australian doctors bring woman back from the dead
Monday, Aug 19, 2013 AFP SYDNEY – An Australian woman has lived to tell the tale after being brought back to life from being clinically dead for 42 minutes, doctors said on Monday. Mother-of-two Vanessa Tanasio, 41, was rushed to Monash Medical Centre in Melbourne last week after a major heart attack, with one of her main arteries fully blocked. She went into cardiac arrest and was declared clinically dead soon after arrival. Doctors refused to give up and used a compression device called a Lucas 2 – the only one of its kind in Australia – to keep blood flowing to her brain while cardiologist Wally Ahmar opened an artery to unblock it. Once unblocked, Ms Tanasio’s heart was shocked back into a normal rhythm. “(I used) multiple shocks, multiple medications just to resuscitate her,” Dr Ahmar said. “Indeed this is a miracle. I did not expect her to be so well.” Ms Tanasio said she had no history of heart conditions and was grateful to be alive. “I remember being on my couch, then the floor, then arriving at hospital, and then two days go missing,” Ms Tanasio said. “I was dead for nearly an hour and only a week later I feel great. It’s surreal.” The Lucas device physically compresses the chest, like during cardiopulmonary resuscitation (CPR), allowing doctors to work non-stop to put a stent into a blocked artery. It is the first time a patient has successfully used the device, which was donated to the medical centre, for such a length of time in Australia, the hospital said. Clinical death is a medical term for when someone stops breathing and their blood stops circulating. Publication: